Replies to post #88434 on NanoViricides Inc. (NNVC)

[Echo20]

Nanopatent

From a hammered sector since February to MERGER MANIA,

The drugs sector is in the grip of a wave of deal-making as firms strive to build up their best businesses and exit weaker ones, as highlighted by a multibillion-dollar asset swap between Novartis and GlaxoSmithKline.


Heating up for SPRING.

Echo20

Two biopharmaceutical companies with major presences in the Triangle announced a five-year collaboration agreement on Thursday.

Drug developer Biogen Idec (Nasdaq: BIIB) and biopharma development and commercial outsourcing services provider Quintiles (NYSE: Q) said they will work more closely together for at least the coming five years in order to improve Biogen's clinical development process

Another merger?

Echo20